Intermediates of Metabolism: From Bystanders to Signalling Molecules by Haas, R et al.
Intermediates of Metabolism: From Bystanders to Signalling Molecules.
Haas, R; Cucchi, D; Smith, J; Pucino, V; Macdougall, CE; Mauro, C
 
 
 
 
 
(c) The Authors, 2016
 
 
For additional information about this publication click this link.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/18257
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
TRENDS BOX 
 
 Metabolic intermediates of biochemical pathways are able to act as intra- and extracellular 
signalling molecules affecting immune cell responses. 
 The signalling effects of metabolites are concentration and localization dependent. 
 Their functions go beyond self-regulatory mechanisms and include cell to cell communication as 
well as sensing of micro-environmental conditions to elicit stress responses and cellular 
adaptation. 
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Summary 14 
 15 
 The integration of biochemistry into immune cell biology has immensely contributed to our 16 
understanding of immune cell function and the associated pathologies. So far, most studies have 17 
focused on the regulation of metabolic pathways during an immune response and their contribution 18 
to its success. More recently, novel signalling functions of metabolic intermediates are being 19 
discovered that might play important roles in the regulation of immunity. Here, we describe the 20 
three long-known small metabolites lactate, acetyl-CoA and succinate in the context of immuno-21 
metabolic signalling. Functions of these ubiquitous molecules are largely dependent on their intra- 22 
and extra-cellular concentrations as well as their sub-compartmental localization. Importantly, the 23 
signalling functions of these metabolic intermediates extend beyond self-regulatory roles and 24 
include cell to cell communication and sensing of micro-environmental conditions to elicit stress 25 
responses and cellular adaptation. 26 
  27 
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Metabolite signaling in immunity 28 
 29 
 The metabolic regulation of immune cells during health and disease has gained a lot of 30 
attention as the active reconfiguration of immune cell metabolism enables these cells to sustain 31 
certain effector functions. The focus so far has been on the necessity of the main catabolic pathways 32 
glycolysis, fatty acid oxidation, the anaplerotic tricarboxylic acid (TCA) cycle and oxidative 33 
phosphorylation as well as amino acid metabolism (Figure 1) during activation, proliferation, 34 
differentiation and function as a response to extracellular signals. 35 
 It is now becoming increasingly evident that small molecule intermediates of these 36 
metabolic pathways, besides their anabolic and catabolic function, can act as intra- and extracellular 37 
signals that influence the outcome of an immune response. The roles of metabolite signalling stretch 38 
from regulation of cytokine production via indirect effects on the cellular redox state [1] or direct 39 
interaction with transcription factors binding the specific cytokine promoter elements [2] and 40 
modulating the activity of transmembrane ion channels [3], to interference with cell migration and 41 
differentiation. Interestingly, a few G-protein coupled receptors that are activated by intermediates 42 
of metabolism have recently been identified supporting a role for metabolites as extracellular signals 43 
[4, 5]. In this review, we discuss the three well known metabolites lactate, succinate and acetyl-CoA 44 
in more detail; identify their differences and similarities in signal transduction and effect on 45 
immunity and inflammation that defines them as novel signalling molecules in physiology and 46 
pathology. 47 
 48 
Lactate is a signalling molecule 49 
 50 
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 Lactate is a ubiquitous molecule, whose presence in the mammalian body was first observed 51 
in muscle tissue at the beginning of the 19th century [6]. Since its discovery, lactate has been 52 
intensely studied and it has been shown to have numerous metabolic functions (Figure 2, Key 53 
Figure), including as a central metabolite in the Cori cycle (also known as the lactic acid cycle), which 54 
mediates metabolic cross talk between the liver and the muscle. In the Cori cycle, muscle tissue 55 
metabolizes liver-derived glucose to lactate, which in turn is shuttled back to the liver and acts as a 56 
fuel source for hepatic gluconeogenesis [7]. By contrast, in the brain lactate acts as a metabolic 57 
signal and fuel for oxidative metabolism, which is the basis of the neuron-astrocyte lactate shuttle 58 
[8]. Briefly, the neurotransmitter glutamate induces high glycolytic activity in astrocytes, which 59 
secrete lactate into the synaptic cleft. The increased availability of extracellular lactate enables 60 
neurons to import it and use it as an alternative fuel source. 61 
 Although lactate has been known to biochemists for over two hundred years, it has been 62 
long neglected, seen as a by-product or a bio-marker at best rather than a bio-active molecule. As a 63 
consequence its potential functional effects have been under appreciated. 64 
 Recently, lactate is being rediscovered as an active signalling metabolite in multiple fields of 65 
biology and medicine that has two main ways of signal transduction – transporter and receptor 66 
mediated. Its direct regulation of global gene transcription [9, 10], endothelial and cancer cell 67 
migration [11, 12], cancer progression [13] and functional polarization of immune cells are being 68 
described [14-16].  69 
 Lactate production occurs mainly in the cytoplasm during hypoxia or aerobic glycolysis in 70 
proliferative cells and is then secreted through the plasma membrane. This transport is dependent 71 
on six so far described solute carrier transporters that perform proton – lactate symport (Mct1-4) or 72 
a sodium-dependent symport (Slc5a8, Slc5a12) [17, 18]. The MCT family harbours 14 members that 73 
all share conserved sequence motifs, yet differ in their substrate specificity, transport rate and 74 
expression pattern [17]. Indeed, only Mct1 (Slc16a1, Km 4.5) and Mct4 (Slc16a3, Km 28) have been 75 
shown to have a high specificity for lactate in concord with broad tissue expression [17, 19]. 76 
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Similarly, sodium-coupled lactate transport is carried out by the ubiquitously expressed high affinity 77 
transporter Slc5a8 or the low affinity transporter Slc5a12 [18]. The transport direction of both 78 
systems depends on the intra- and extracellular concentration of lactate, favouring lactate import 79 
(even through low affinity transporters) only in the presence of high extracellular lactate 80 
concentrations. 81 
 The physiological lactate concentration is about 1.5mM – 3mM [18] in blood and healthy 82 
tissues, but can rise up to 10mM in inflammatory pathologies such as atherosclerotic plaques or 83 
rheumatic synovial fluid and even up to 20-30mM in cancerous tissue [14, 15, 20]. Far from being 84 
inert, accumulating lactate – a feature of most inflammatory sites – has tremendous effects on 85 
tissue resident or infiltrating immune cells as well as stromal cells. In the tumour microenvironment, 86 
lactate produced by tumour cells is taken up by macrophages where it promotes polarization 87 
towards Arginase 2 (Arg2) expressing M2-like phenotype via Hypoxia inducible factor 1α (Hif-1α) 88 
stabilization and the resulting increased production of vascular endothelial growth factor (VEGF). 89 
These effects further enhance tumour growth in a vicious loop [14]. The authors applied unbiased 90 
high-throughput platforms to look for hypothetical protein factors perpetuating such vicious loop, 91 
but surprisingly found lactate as the orchestrating factor. Similarly, an independent study recently 92 
found lactate to be the driving force behind tumour associated macrophage (TAM) development 93 
during epithelial to mesenchymal transition [16]. 94 
 The involvement of Hif-1α in the response to lactate is currently under scrutiny. On the one 95 
hand, it has been demonstrated that targeting the lactate transporter Mct1 in endothelial cells or 96 
cervix squamous carcinoma cells rescues lactate-mediated Hif-1α activation and inhibits the 97 
consequential angiogenesis [21, 22]. On the other hand, these authors could show a lactate 98 
mediated Hif-1α independent induction of angiogenesis. Here, reactive oxygen species (ROS) 99 
induced the NF-κB pathway that led to IL-8 expression, a known chemotactic molecule that resulted 100 
in increased cell migration and tumour metastasis [23]. Additionally, a recent study demonstrates 101 
the Hif-1α independent, direct binding of lactate to NDRG3 during hypoxia. Upon lactate binding, 102 
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NDRG3 is stabilized and executes a Raf-ERK1/2 mediated signalling cascade promoting angiogenesis 103 
and cell growth [24]. Surprisingly, not only migration-promoting but also inhibiting functions of 104 
lactate have been described. 105 
 Activated T cells that infiltrate inflammatory sites are exposed to the increased lactate 106 
concentration that is commonly found in these sites (e.g., 10-12mM in arthritic synovium) [15]. Due 107 
to the high extracellular concentration, lactate internalization through the CD8+ T cell specific 108 
transporter Mct1 and CD4+ T cell specific transporter Slc5a12 is favoured. This inhibits glycolysis via 109 
inhibition of Pfk or downregulation of Hk1 [15, 25], causing T cells to lose their responsiveness to 110 
chemokines and effectively trapping them in the inflamed site. Of note, these effects are not only 111 
observed in in vitro assays; in an animal model of peritonitis, lactate levels and T cell numbers in the 112 
peritoneum are indeed increased 5 days after intra peritoneal (i.p.) injection with zymosan, a glucan 113 
commonly used to induce sterile inflammation. Of note, inhibition of lactate transporters re-114 
establishes T cell migration not only in vitro but also in the peritonitis model [15]. These findings 115 
describe a mechanism explaining at least in part the well-known clinical observation that T cells are 116 
entrapped in inflamed tissue [15] (Figure 2). 117 
 In addition, lactate also triggers the production of the pro-inflammatory cytokine IL-17 in the 118 
CD4+ subset and inhibits the cytolytic function of cytotoxic CD8+ T cells (CTL) (Figure 2). The observed 119 
inhibition of CTL function was also reported in an earlier publication, showing that both proliferation 120 
and cytokine production in human CTLs is severely impaired in the presence of lactic acid [26]. 121 
 The observed effects of T cell entrapment, CTL inhibition and increased production of pro-122 
inflammatory cytokines are common features of many chronic inflammatory diseases that might be 123 
in part explained by lactate signalling. The detailed molecular mechanisms for lactate mediated 124 
inhibition of T cell migration and change in function, however, are yet to be elucidated. 125 
 126 
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 Interestingly, the above effects of lactate/lactic acid on macrophages, endothelial cells and T 127 
cells are independent of the pH change that is caused by the acidic form of lactate [15, 16], yet 128 
protons are still required for the translocation of lactate into the cytoplasm [15]. 129 
 Additional evidence establishing lactate as a signalling molecule comes from the 130 
identification of the lactate receptor Gpr81, first cloned in 2001 [27]. Seven years later, lactate was 131 
identified as the primary ligand for Gpr81, being involved in lactate-mediated reduction of lipolysis 132 
in adipocytes, the primary Gpr81-expressing cell type [4]. It is now known that Gpr81 is a G-protein 133 
coupled receptor that inhibits adenylyl cyclase via the Gi signalling pathway [28] and mediates the 134 
insulin-induced reduction of lipolysis [29, 30]. Interestingly, several reports identify lactate receptor 135 
activation as a critical survival signal for cancer cells [31, 32], and define it as a therapeutic target in 136 
ischemic brain injury [33] (Figure 2). 137 
 In contrast to the roles of lactate on cell signalling, its effect on regulating other metabolic 138 
pathways is better understood. Once in the cytoplasm, lactate is readily oxidized to pyruvate by 139 
lactate dehydrogenase (LDH). This reaction proceeds with a concomitant proton transfer from 140 
lactate to nicotinamide dinucleotide (NAD+) thereby generating NADH and affecting the redox state 141 
of the cell (see Glossary). Although LDH is mainly considered a cytoplasmic enzyme, after years of 142 
controversy the existence of a mitochondrial LDH has finally been proven [34]. Thus, given the 143 
presence of Mct1 in the mitochondrial membrane [35], lactate metabolism is now being considered 144 
as an active part of mitochondrial metabolism. Recently, the LDH subunit B (LDHB) has also been 145 
shown to localize to peroxisomes in fibroblasts and HeLa cells [36]. This might be a hint towards the 146 
possible involvement of lactate in fatty acid oxidation or lipid metabolism in general as discussed in 147 
the following excellent review [37]. 148 
 Contrarily, the effects on glycolysis remain questionable. It was shown that 10mM 149 
extracellular lactate inhibits glycolytic activity in T cells, which could be facilitated by downregulation 150 
of hexokinase 1 or direct inhibition of phosphofructokinase. By contrast, in heart tissue lactate 151 
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causes increased Glut1 and Glut4 expression on the plasma membrane, which is in general an 152 
indicator of increased glucose uptake and flux [38].  153 
 Taken together, lactate-induced signalling is an important pathway in health and disease. As 154 
discussed here, lactate has two primary means of relaying signals into the cell (receptor- and 155 
transporter-mediated), and lactate signalling has several possible outcomes that depend on the cell 156 
type. Moreover, the concentration of extracellular lactate that lie between 1.5mM in physiological 157 
and 10-30mM in pathological settings has immense impact on cell function as it will lead to the 158 
activation of different signalling pathways. 159 
 160 
Effects beyond metabolism of TCA cycle intermediates: focus on succinate 161 
 162 
 It is now becoming clear that the reaction intermediates of the TCA cycle (Figure 1; Box 1) 163 
can act as proper signalling molecules once they are withdrawn from the cycle and redirected 164 
towards different functions. This occurs both in physiological and pathological conditions; for 165 
instance, citrate accumulates in the cytosol of Lipopolysaccharide (LPS) -treated macrophages where 166 
it is necessary for the synthesis of NO, ROS and prostaglandins [39]. Fumarate has been recently 167 
defined as a proto-oncometabolite [40, 41] because its accumulation, due to loss of function 168 
mutations in the fumarate hydratase (FH) (see Glossary) [42, 43], results in stabilization of Hif-1α via 169 
two different mechanisms: the inhibition of PHD2 (prolyl hydroxylase domain-containing protein 2), 170 
which targets HIF factors for degradation [44], and the amplification of ROS signalling through the 171 
consumption of reduced glutathione and NADPH [41]. Another TCA cycle metabolite that can 172 
regulate non-metabolic activities is NAD+, an important cofactor for sirtuins, a family of deacetylases 173 
that targets important transcription factors of the inflammatory response, such as NF-kB [45] and 174 
AP1 [46], and controls mitochondrial quality and biogenesis [47]. 175 
 For the rest of this section we focus on succinate, as in the past few years it has been 176 
reported to be a central metabolite in the biology of immune cells (such as macrophages) as well as 177 
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in cancer and other pathological contexts, providing a clear example of a new potential therapeutic 178 
target.  179 
Succinate is synthesized from α-ketoglutarate (first converted to succinyl-CoA and then to 180 
succinate) and subsequently utilized as a substrate by succinate dehydrogenase (SDH) to produce 181 
fumarate (Figure 3). Inhibition of SDH results in accumulation of succinate, stabilization of Hif-1α, 182 
induction of Hif-1α transcriptional activity and oncogenic events. Stabilization of Hif-1α is due to the 183 
ability of succinate to inhibit PHD enzymes (prolyl hydroxylases). Hydroxylation of HIF by PHD 184 
enzymes is necessary for its binding to pVHL, part of an E3 ubiquitin ligase targeting HIF for 185 
degradation [48]. Thus, reduction of this hydroxylation results in HIF stabilization leading to the 186 
transcription of genes involved in proliferation, angiogenesis and metastasis [49] (Figure 3). 187 
 Stabilization of Hif-1α by succinate was also observed in LPS-treated macrophages and was 188 
associated with enhanced production of IL-1β [2]. The authors observed an accumulation of 189 
succinate in macrophages after Toll-like receptor 4 (TLR4) engagement by LPS, which was 190 
responsible for the stabilization of Hif-1α. The stabilization of Hif-1α in activated macrophages was 191 
directly linked to the increased transcription and production of IL-1β; indeed, the authors 192 
demonstrated that Hif-1α can bind the promoter of IL-1β, activating its transcription. LPS-treated 193 
macrophages undergo a switch from oxidative phosphorylation to glycolysis, lowering the activity of 194 
the TCA cycle, which raises questions as to the source of succinate accumulation. Indeed, the main 195 
source of succinate after LPS treatment appears to be glutamine, mainly via anaplerosis of α-196 
ketoglutarate feeding into the TCA cycle and replenishing succinate, and, to a lesser extent, via the 197 
GABA (γ-aminobutyric acid) shunt (Figure 3). These findings suggest succinate is an inflammatory 198 
signal that is necessary to activate macrophages and stabilize a fundamental player of immune 199 
response, Hif-1α, leading to the production of IL-1β [2] (Figure 3).  200 
 A new depth of understanding of the metabolic rewiring of intracellular metabolism was 201 
obtained by a study that used metabolomics and transcriptomics to characterize, in detail, the 202 
changes that occur in macrophages during polarization towards M1 or M2 phenotypes [50]. With 203 
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regard to M1 polarization, they identified two TCA cycle break-points: the first at the conversion 204 
point of citrate to α-ketoglutarate, and the second after succinate synthesis at the conversion point 205 
of succinate to fumarate. The first break-point, due to the downregulation of isocitrate 206 
dehydrogenase, results in citrate accumulation, which is then redirected towards production of 207 
itaconic acid, an anti-microbial metabolite [51]. The authors also described a second break-point, at 208 
the TCA step of converting succinate into fumarate; succinate accumulation increased, as previously 209 
reported [2]. Despite the low efficiency of succinate to fumarate conversion, an accumulation of 210 
malate (produced from fumarate) was also observed. This was due to the upregulation of the 211 
arginosuccinate shunt, a series of reactions feeding first into fumarate and then malate. This shunt is 212 
important not only to replenish malate and subsequently citrate (to complete the cycle) but also to 213 
produce NO and IL-6, both necessary for appropriate activation of macrophages [50]. 214 
Ischaemia reperfusion (IR) also causes the specific accumulation of succinate and 215 
subsequent production of mitochondrial ROS. Production of ROS during ischaemia reperfusion has 216 
always been thought to be a nonspecific response due to reperfusion; however, a recent study 217 
demonstrates that succinate accumulation during reperfusion of ischaemic tissues is a selective 218 
response that drives the generation of ROS responsible for tissue damage [52]. Using an in vivo 219 
model of ischaemia in combination with unsupervised metabolomics analysis, succinate was found 220 
to specifically accumulate during ischaemia in different tissues (liver, kidney, heart and brain) and it 221 
was rapidly re-oxidized during reperfusion. To assess the source of succinate, they performed stable 222 
isotope tracing experiments and found that succinate derived mainly from the malate/aspartate 223 
shuttle (MAS) and the purine nucleotide cycle (PNC) (Figure 3). These two pathways led to the 224 
accumulation of fumarate which was then converted to succinate by the reversal of SDH. During 225 
reperfusion the accumulated succinate was rapidly re-oxidized to fumarate by SDH, leading to a 226 
massive production of mROS, mainly superoxide (Figure 3), due to the reverse electron transport 227 
(RET) through mitochondrial complex I (see Box 1) [52]. This observation describes succinate as a 228 
damage signal during reperfusion, making it an intriguing target for therapy development. 229 
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 In addition to these intracellular non-metabolic effects of succinate, it also binds to a specific 230 
receptor localized onto the cytoplasmic membrane, which suggests it can signal as an extracellular 231 
molecule (Figure 3). The succinate receptor, GPR91 (also known as SUCNR), is a G protein-coupled 232 
receptor whose activation triggers intracellular calcium release and inhibits cAMP production.  In 233 
mouse, it is expressed mainly in the kidney, liver, spleen and small intestine [5]. GPR91 is expressed 234 
on human and mouse dendritic cells (DC), where it enhances their immune-stimulatory capacity 235 
[53]. Specifically, succinate stimulation of GPR91 promotes migration of DC in a dose-dependent 236 
manner, and it cooperates with TLR ligands to induce cytokines via Erk1/2 phosphorylation. 237 
Furthermore, succinate sustains and empowers DC-mediated T cell activation. These effects were 238 
shown to be dependent on succinate stimulation of GPR91, as they were abrogated in Sucnr-/- mice 239 
[53]. 240 
 241 
Immune regulation by fatty acid oxidation: in search of a signalling role for lipid intermediates 242 
  243 
 Unlike glycolysis and the TCA cycle, the intermediates of fatty acid metabolism have not yet 244 
been shown to regulate T cell fate and functional specification (Figure 1 and Box 1). However, both 245 
the induction of fatty acid synthesis (FAS) and its inverse metabolic pathway, fatty acid oxidation 246 
(FAO), have been linked to T cell function. Specifically, while the induction FAS is known to be an 247 
integral part of the T cell activation program that is associated with increased glucose metabolism, 248 
which is essential for the differentiation of naïve T cells into their T effector subsets, FAO has been 249 
shown to be critical for the development of CD8+ memory T cells and the induction of CD4+ 250 
regulatory T cells [54, 55] (Figure 4).   251 
Mice with a T cell-specific deletion of tumour necrosis factor (TNF) receptor-associated 252 
factor 6 (TRAF6) displayed a profound defect in CD8+ memory T cell generation, and were unable to 253 
upregulate FAO after growth factors withdrawal during contraction phase of immune response. 254 
TRAF6-deficient CD8+ T cells exhibited defective AMP-activated kinase (AMPK) activation, whereas 255 
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activation of AMPK with metformin was able to rescue both FAO and the generation of CD8+ 256 
memory T cells, suggesting TRAF6 regulates a metabolic switch towards FAO important for 257 
generation of long-lived CD8+ memory T cells [54]. Regulatory CD4+ T cells (Tregs) have also been 258 
shown to rely primarily on FAO during their development [55, 56]. Naturally occurring Tregs display 259 
low levels of Glut1, and thus low rates of glycolysis, while having increased activation of AMPK. 260 
Treatment with etomoxir, an inhibitor of carnitine palmitoyl transferase (CPT1), the rate limiting 261 
enzyme in FAO, was sufficient to abrogate Treg development, suggesting that FAO is essential for 262 
Treg development [55]. 263 
 Interestingly, it has recently been demonstrated that the increase in FAO in memory CD8+ T is 264 
surprisingly the direct result of de novo FAS, rather than uptake of fatty acids from the extracellular 265 
environment [57]. After observing no increase in extracellular fatty acid uptake, the authors showed 266 
that extracellular glucose fuels mitochondrial fatty acid oxidation and oxidative phosphorylation 267 
(OXPHOS) indicating that fatty acids are synthesised for subsequent oxidation. Upon treatment with 268 
a fatty acid synthase inhibitor, memory T cell death increased suggesting fatty acid synthesis is 269 
necessary for their survival. Memory T cells lack typical fatty acid storage droplets; instead, 270 
lysosomal acid lipase (LAL) activity plays a role in non-classical fatty acid storage.  LAL is required for 271 
lipolysis of stored fatty acids to generate available fatty acids for oxidation and necessary for 272 
memory T cell survival. These data support the phenomenon known as fatty acid “futile cycling” 273 
whereby intracellular fatty acids are catabolized rather than acquired from extracellular sources, for 274 
use in the mitochondria for fatty acid oxidation. With no net gain of ATP, this cycling of fatty acids is 275 
bio-energetically redundant. However, it has been suggested that fatty acid cycling in memory T cells 276 
may provide a mechanism to maintain their survival and, sustaining their glycolytic and 277 
mitochondrial metabolism, may enable rapid recall responses after antigen recognition.  278 
 Extracellular signalling by IL-7 and IL-15 has been shown to impact on T cell development by 279 
affecting FAO [58, 59] (Figure 4). The cytokine IL-15, which is critical for the development and 280 
maintenance of CD8+ memory cells, enhanced the expression of the rate-limiting FAO enzyme CPT1, 281 
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and thus FAO. Importantly, blocking CPT1 with etomoxir impaired the mitochondrial spare 282 
respiratory capacity (see Glossary) and survival of CD8+ memory T cells. Conversely, over-expression 283 
of CPT1 increased the formation of CD8+ memory T cells following infection [58].  IL-7 is known to 284 
control CD8+ memory T cell longevity and homeostasis [60, 61]. Recent findings demonstrate a new 285 
pathway in which IL-7 promotes survival via glycerol import, triglyceride synthesis and storage. 286 
Triglycerides are synthetized combining glycerol-3-phosphate and Acyl-CoAs (free fatty acids 287 
activated with a Coenzyme-A moiety), thus the amount of glycerol affects triglyceride synthesis. In 288 
this study IL-7 was shown to induce expression of the glycerol channel aquaporin 9 (AQP9), which 289 
was required for long term survival of CD8+ memory cells. AQP9 deficiency resulted in impaired 290 
glycerol import, and thus esterification of fatty acids and reduced triglyceride synthesis and storage. 291 
These defects were rescued by ectopic expression of triglyceride synthases, which restored lipid 292 
stores and CD8+ memory T cells [59].  293 
 Acyl-CoA is the main intermediate metabolite of lipid metabolism within the cell. FAO 294 
involves the sequential removal of 2-carbon units from a fatty acyl-CoA molecule to yield acetyl-CoA, 295 
which can be directly shuttled into the TCA cycle. While intermediate products of glycolysis and the 296 
TCA cycle have been shown to have active signalling roles, little research has been done into 297 
whether FAO metabolites may have direct effects on the cell fate decision of T cells. However, a 298 
recent paper has shown that long chain acyl-CoAs, which are the activated form of free fatty acids 299 
and represent the pre-step reaction for β-oxidation, can act as positive modulators of ion channels 300 
and exchangers [3]. Specifically, long chain acyl-CoAs were shown to be potent activators of TRPV1 301 
cation channels independently of Ca2+, and increasing the level of long chain acyl-CoAs in intact 302 
Jurkat T cells leads to a significant increase in agonist-induced Ca2+ levels. This novel mechanism 303 
indicates that long chain acyl-CoAs could play an active role in T cell functions under both 304 
physiological and pathophysiological conditions that alter fatty acid transport and metabolism. 305 
 Acetyl-CoA, the end product of FAO, has also been implicated to have roles beyond the TCA 306 
cycle, as it can also act as a substrate for post-translational modifications such as acetylation [62]. 307 
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One potential mechanism is through histone acetylation, which is known to be important for 308 
promoting gene transcription. In the context of immune cells, CD8+ T cells histone acetylation occurs 309 
at specific loci and may be involved in determining the decision between memory and short-lived 310 
effector cell fate [63].  Similarly, different histone acetylation patterns have been shown in CD4+ 311 
effector T cells compared to CD4+ Tregs. Specifically, in Tregs there is increased acetylation of the 312 
Foxp3 locus [64], whereas in T effector cells the IL-13, IL-15 and IL-4 loci have all been shown to have 313 
increased acetylation induced by IL-4 [65]. 314 
 315 
Concluding remarks 316 
 317 
 The discovery of extra-metabolic functions of metabolic enzymes (referred to as moon-318 
lighting) has been the first evidence that metabolism and its players have a role in the regulation of 319 
signalling pathways inside cells. Here, we have described how a similar concept applies to 320 
metabolites, which for decades were considered to be only the building blocks of biomasses. The 321 
observation that intermediates and end products of the main metabolic pathways can desert their 322 
metabolic roles to function, in certain circumstances, as transduction signals shows how these 323 
molecules can play an active and crucial role in regulating some of the most important biological 324 
processes. We currently have evidence that some metabolites play roles in the immune and 325 
inflammatory responses, and influence cytokine production, proliferation and angiogenesis, both in 326 
physiology and pathology. It remains to be established if other metabolites might display similar 327 
functions. 328 
 In this new scenario, the accumulation or the depletion of specific metabolites does not 329 
represent just a metabolic adaptation or a choice merely dictated by energy demand; it is rather an 330 
elected form of signalling-mediated regulation of biological processes. The loss of this intrinsic 331 
regulation is associated with several pathological conditions, and this might explain the current 332 
efforts to target metabolic pathways for therapeutic purpose. In doing so, we need to bear in mind 333 
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that some processes, such as ROS production, are necessary but must be tightly regulated to 334 
maintain homeostasis; hence in some cases mild intervention could be safer and even more 335 
beneficial than blunt blockade.  336 
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BOX1 - Basics of TCA cycle, FAO and ETC/RET  346 
 347 
TCA cycle 348 
 The tricarboxylic acid (TCA) cycle, also known as citric acid cycle or Krebs Cycle, is a series of 349 
biochemical reactions occurring into the mitochondrion that provide energy and reducing 350 
equivalents through the complete oxidation of acetate, in form of acetyl-CoA, produced from the 351 
breakdown of sugars, lipids and amino-acids (Figure 1). 352 
 353 
FAO 354 
 Fatty acids are an alternative source of fuel for cells yielding large amounts of ATP during 355 
their oxidation. This catabolic process occurs in the mitochondria to generate acetyl-CoA, which 356 
directly enters into the TCA cycle (Figure 1). 357 
 358 
ETC 359 
The mitochondrial electron transport chain (ETC) is a series of protein complexes embedded into the 360 
inner mitochondrial membrane responsible for the transfer of electrons from donors to acceptors 361 
via redox reactions. The transfer of electrons through the chain is coupled to the pumping of protons 362 
into the intermembrane space. This proton gradient provides the proton-motive force necessary for 363 
the generation of energy in the form of ATP. In eukaryotes, ETC is composed of 4 complexes: 364 
complex I or NADH dehydrogenase, which oxidizes NADH and transfers electrons to ubiquinone Q 365 
(thus turned to ubiquinol QH2) while pumping four protons into the intermembrane space; complex 366 
II or succinate dehydrogenase, which oxidizes succinate to fumarate and transfers electrons to 367 
ubiquinone; complex III or cytochrome c oxidoreductase, which re-oxidizes ubiquinol to ubiquinone 368 
while reducing cytochrome c and pumping two protons across the membrane; and complex IV or 369 
cytochrome c oxidase, which oxidizes cytochrome c passing electrons to the final acceptor of the 370 
chain, molecular oxygen O2, generating water and pumping four protons across the membrane. 371 
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Finally, ATP synthase utilizes the energy stored into the protons gradient to phosphorylate ADP to 372 
ATP. Complex I and II represent two independent entry points to the ETC. 373 
 374 
RET  375 
Reverse electron transfer (RET) is the flow of electrons from ubiquinone to NAD+ catalysed by 376 
complex I in the presence of a reduced pool of QH2 and a high proton gradient forcing electrons 377 
backward from QH2 into complex I, which leads to the production of superoxide [66, 67]. 378 
 379 
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GLOSSARY  381 
REDOX STATE 382 
The cellular redox state is often described as the balance of reduced and oxidized glutathione 383 
(GSH/GSSG), Nicotinamidedinuclotide (NAD+/NADH) and Nicotinamidedinuclotide-phosphate 384 
(NADP+/NADPH). These redox couples are central mediators for catabolic and anabolic reactions 385 
acting as cofactors and regulators for enzymes, scavengers for reactive oxygen species or substrates 386 
for the mitochondrial electron transport chain. 387 
FUMARATE HYDRATASE (FH): 388 
The TCA cycle enzyme responsible for the conversion of fumarate to malate. 389 
SPARE RESPIRATORY CAPACITY: 390 
The extra capacity available in cell to produce energy via mitochondrial respiration. 391 
 392 
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FIGURE LEGENDS 394 
 395 
Figure 1 – Metabolic pathways and regulatory intermediates of metabolism. The main cellular 396 
catabolic pathways (glycolysis: blue; tricarboxylic acid (TCA) cycle: red; fatty acid oxidation (FAO): 397 
green) not only produce ATP, but also metabolic intermediates, such as lactate, acetyl-CoA and 398 
succinate, highlighted in colour. These are substrates for anabolic processes including lipid and 399 
nucleotide synthesis, but can also act as regulatory signalling molecules. 400 
 401 
Figure 2, Key Figure – Lactate-mediated signalling pathways and their biological outcomes. 402 
Extracellular lactate (left side of the figure) has staggering functional effects on several cell types, 403 
including production of pro- and anti-inflammatory mediators by T cells and macrophages (Mφ), or 404 
migratory changes and metabolic adaptation in T cells, endothelial cells (EC) and neurons. 405 
Intracellularly (right side of the figure), lactate can directly bind to proteins (i.e. NDRG3), influence 406 
the redox state via the lactate dehydrogenase (LDH) reaction, stabilize Hif-1α, induce reactive 407 
oxygen species (ROS) and act as an inhibitor of glucose breakdown. The occurrence of these effects 408 
might depend on the investigated cell type. 409 
 410 
Figure 3 – Succinate signalling and its biological effects. Succinate exerts several biological 411 
responses. By stabilizing Hif-1α, it promotes proliferation, angiogenesis and cytokine production. 412 
Succinate can also regulate proteins activity via succinylation. During ischaemia, fumarate 413 
accumulates through the malate-aspartate shuttle (MAS) and the purine nucleotide cycle (PNC) and 414 
is converted into succinate by succinate dehydrogenase reversal (SDH); during reperfusion, the rapid 415 
re-oxidation of succinate to fumarate by SDH leads to the production of mitochondrial reactive 416 
oxygen species (mROS) responsible for tissue damage. Furthermore, succinate in the extracellular 417 
microenvironment can signal through its receptor (GPR91), sustaining cytokine production and 418 
migration of dendritic cells (DC). TCA, tricarboxylic acid cycle; AMP, adenosine monophosphate; IMP, 419 
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inosine monophosphate; PHD, prolyl hydroxylases; GABA, γ-aminobutyric acid; IR, ischeamia-420 
reperfusion. 421 
 422 
Figure 4 – Fatty acids oxidation and its role in signalling. FAO has been shown to be necessary for 423 
CD8+ memory T cells survival and CD4+ regulatory T cells induction. Moreover, upregulation of 424 
glycerol transporter AQP9 by cytokines is important to increase triglycerides synthesis and thus FAO. 425 
The futile cycling of lipolysis and subsequent FAO seems to be important for memory T cell survival.  426 
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OUTSTANDING QUESTIONS BOX 
 
 Lactate has two primary means of relaying signals into the cell, receptor- and transporter 
mediated, and depending on the cell type has several possible outcomes. The downstream 
pathways still need to be worked out and might illuminate new knowledge in the near future. 
 Besides succinate, other metabolites of the TCA cycle might be directly regulating immune cell 
functions but this is yet to be fully investigated. 
 Unlike glycolysis and the TCA cycle, whose intermediates have been shown to play important 
roles in determining specific T cell fates and functional specifications, the same has yet to be 
defined for the cellular metabolism of fatty acids. 
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